Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrest Nicholson Regulatory News (CRST)

Share Price Information for Crest Nicholson (CRST)

Share Price is delayed by 15 minutes
Get Live Data
67.70    -1.50 (-2.17%)
Bid:
67.30
Ask:
67.80
Spread: 0.50 (0.743%)
Market Cap: £173.81m
CRST Live PriceLast checked at - London Stock Exchange

Intraday Crest Nicholson Share Chart

Form 8.3 - Crest Nicholson Holdings Plc

17 Jul 2024 10:07

Norges Bank - Form 8.3 - Crest Nicholson Holdings Plc

Norges Bank - Form 8.3 - Crest Nicholson Holdings Plc

PR Newswire

LONDON, United Kingdom, July 17

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Norges Bank
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeCrest Nicholson Holdings plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:N/A
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure16/07/2024 Dealing disclosure
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”Yes Bellway plc

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:5p ordinary
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:7,537,0682.93%
(1) Relevant securities owned and/or controlled:
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:7,537,0682.93%

*Norges Bank does not have discretion regarding dealing and offer acceptance decisions with respect to 5,090,732 shares that are included in the total above. 

All interests and all short positions should be disclosed.

-Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

Purchases and sales
Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
5p ordinarySale22,981GBP 2.5278

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO
Date of disclosure:17/07/2024
Contact name:Philippe Chiaroni
Telephone number:+47 2407 3000

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.



Date   Source Headline
29th May 202610:34 amRNSADMISSION TO TRADING AND TOTAL VOTING RIGHTS
21st May 20269:52 amRNSHolding(s) in Company
20th May 20262:28 pmRNSHolding(s) in Company
19th May 20267:00 amRNSRevised date for the half year results
12th May 20262:09 pmRNSDirector/PDMR Shareholding
1st May 20264:26 pmRNSHolding(s) in Company
30th Apr 20264:04 pmRNSADMISSION TO TRADING AND TOTAL VOTING RIGHTS
28th Apr 20262:56 pmRNSDirector/PDMR Shareholding
24th Apr 20264:47 pmRNSDirector/PDMR Shareholding
21st Apr 20267:00 amRNSTrading Update
20th Apr 20265:21 pmRNSHolding(s) in Company
10th Apr 20264:14 pmRNSDirector/PDMR Shareholding
7th Apr 20269:57 amRNSAdmission to Trading
31st Mar 20263:23 pmRNSTotal Voting Rights
26th Mar 20263:24 pmRNSDirector/PDMR Shareholding
25th Mar 202611:59 amRNSResult of AGM
25th Mar 20267:00 amRNSTrading Statement
24th Mar 20268:45 amRNSDirector/PDMR Shareholding
10th Mar 20264:40 pmRNSDirector/PDMR Shareholding
10th Mar 20264:40 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:22 pmRNSDirector/PDMR Shareholding
27th Feb 20262:37 pmRNSTotal Voting Rights
17th Feb 202610:38 amRNSAnnual Report & Notice of AGM
10th Feb 20265:04 pmRNSDirector/PDMR Shareholding
30th Jan 20262:11 pmRNSTotal Voting Rights
29th Jan 20267:00 amRNSFinal Results
12th Jan 20265:02 pmRNSDirector/PDMR Shareholding
23rd Dec 20253:46 pmRNSTotal Voting Rights
23rd Dec 20253:46 pmRNSTotal Voting Rights
10th Dec 20254:07 pmRNSDirector/PDMR Shareholding
5th Dec 202510:22 amRNSDirector Declaration
28th Nov 20252:55 pmRNSTotal Voting Rights
19th Nov 202512:59 pmRNSHolding(s) in Company
18th Nov 20257:00 amRNSTrading Statement
11th Nov 202512:32 pmRNSDirector/PDMR Shareholding
5th Nov 202510:40 amRNSHolding(s) in Company
31st Oct 20255:07 pmRNSTotal Voting Rights
28th Oct 202511:06 amRNSHolding(s) in Company
28th Oct 202510:02 amRNSDirectorate Change
24th Oct 20253:05 pmRNSHolding(s) in Company
17th Oct 202510:08 amRNSBlock listing Interim Review
10th Oct 20254:21 pmRNSDirector/PDMR Shareholding
30th Sep 202512:07 pmRNSTotal Voting Rights
22nd Sep 20252:48 pmRNSHolding(s) in Company
11th Sep 20254:07 pmRNSDirector/PDMR Shareholding
3rd Sep 20253:48 pmRNSHolding(s) in Company
29th Aug 20251:28 pmRNSTotal Voting Rights
13th Aug 20259:58 amRNSDirector/PDMR Shareholding
1st Aug 20254:46 pmRNSHolding(s) in Company
31st Jul 20252:10 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.